Jamie Rowen, Associate Professor of Legal Studies and Political Science, has co-authored a piece examining the medical misinformation and questionable legal reasoning about abortion behind recent anti-mifepristone court decisions, such as the decision by U.S. District Judge Matthew J. Kacsmaryk in Texas overturning the FDA’s approval of the drug. “Judge Kacsmaryk frames the decision as one designed to protect women and girls, yet mifepristone is a drug that has more benefits than just safe abortion,” Rowen and her co-author write. “It has been shown in numerous studies to help women safely treat an incomplete miscarriage and is now used off label for this purpose. Studies have also shown mifepristone to be helpful with labor induction, increasing the safety of the delivery process for someone who does continue with a pregnancy. Ongoing research into other applications for mifepristone may be interrupted by these judges’ decisions that limit the ways the drug can be used.” (Yahoo!News, New Haven Register, SF Gate, Houston Chronicle, PennLive [all via The Conversation], 4/14/23)